ENLIVEN THERAPEUTICS INC (ELVN) Stock News

USA - NASDAQ:ELVN - US29337E1029 - Common Stock

21.19 USD

-0.93 (-4.2%)

Last: 10/21/2025, 8:10:41 PM

21.19 USD

0 (0%)

After Hours: 10/21/2025, 8:10:41 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ELVN Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Zacks Investment Research

Enliven Therapeutics, Inc. (ELVN) Upgraded to Buy: Here's What You Should Know

2 months ago - By: Zacks Investment Research

How Much Upside is Left in Enliven Therapeutics, Inc. (ELVN)? Wall Street Analysts Think 102.41%

2 months ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2025 Annual Meeting

2 months ago - By: The Motley Fool

Enliven Posts Loss Beat and Cash Surge

a year ago - By: InvestorPlace

ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q2 2024

2 months ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

4 months ago - By: Benzinga - Mentions: ROST CMG CNC MO ...

Meta To Rally Around 3%? Here Are 10 Top Analyst Forecasts For Wednesday

4 months ago - By: Stocktwits - Mentions: GS

Enliven Short Interest Falls To 14-Month Low After Leukemia Trial Data, Goldman Initiates With ‘Buy’

4 months ago - By: Yahoo Finance - Mentions: GS NVS NOVN

Enliven Therapeutics, Inc. (ELVN) Backed by Goldman Sachs After Strong Trial Data

4 months ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

a year ago - By: BusinessInsider

News Image

ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q2 2024

4 months ago - By: Yahoo Finance - Mentions: KULR CRWV NOVN

Why KULR Technology Stock Is Plummeting Today

4 months ago - By: Benzinga - Mentions: TLSA HCTI SNES NCNA ...

12 Health Care Stocks Moving In Friday's Intraday Session

4 months ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

4 months ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

4 months ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001 in CML at EHA 2025 Congress

a year ago - By: BusinessInsider

News Image

ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q1 2024

5 months ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics to Present at Upcoming Investor Conferences

5 months ago - By: Yahoo Finance

Enliven price target lowered to $27 from $36 at JonesResearch

5 months ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update

5 months ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001 in CML and Oral Presentation at the EHA 2025 Congress

7 months ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Announces Poster Presentations at the 2025 AACR Annual Meeting

7 months ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

8 months ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

a year ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update

a year ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics to Present at the Jefferies London Healthcare Conference

a year ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia

a year ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics Announces Details Regarding the Presentation of Updated ELVN-001 Phase 1a Data at the ESH-iCMLf 26th Annual John Goldman Conference on CML

a year ago - By: Enliven Therapeutics, Inc.

Enliven Therapeutics to Present at Two Upcoming Investor Conferences